← Leaderboards
Vladimir P Torchilin
Northeastern University
$17,600,879
Attributed
$19,189,442
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$31,624,023 · 15
By mechanism
U54$17,069,283 · 4
R01$11,789,862 · 8
U01$2,382,844 · 1
R21$372,034 · 1
R13$10,000 · 1
Top collaborators
- Dmitri Lapotko4 shared
- Mien-Chie Hung2 shared
- Surya Nauli2 shared
- Paul J Chiao1 shared
- Vikrant Sharma1 shared
Most similar at Northeastern University
Same institution · by research overlap
- Bryan Quilty Spring$5,650,243
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsPharmaceutical PreparationsBaseTumorIn VitroCellsCancer CellMicellesIn VivoAntibodiesPreparationNanocarrierSurfaceLigandsLiposomesPolyethylene GlycolsPropertyMediatingProtocols DocumentationPeptidesDrug Delivery SystemsApoptosisDrug CarriersBiological
Grant awards (68)
Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance$509,562
U01 · FY2020 · CA
Lipid-dendrimer micellar nanocarriers for siRNA/drug co-delivery in MDR cancer$349,679
R01 · FY2020 · CA · contact PI
Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance$363,193
U01 · FY2019 · CA
Lipid-dendrimer micellar nanocarriers for siRNA/drug co-delivery in MDR cancer$339,188
R01 · FY2019 · CA · contact PI
Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance$505,567
U01 · FY2018 · CA
Lipid-dendrimer micellar nanocarriers for siRNA/drug co-delivery in MDR cancer$349,679
R01 · FY2018 · CA · contact PI
Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance$464,964
U01 · FY2017 · CA
Lipid-dendrimer micellar nanocarriers for siRNA/drug co-delivery in MDR cancer$341,201
R01 · FY2017 · CA · contact PI
Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance$539,558
U01 · FY2016 · CA
Lipid-dendrimer micellar nanocarriers for siRNA/drug co-delivery in MDR cancer$340,703
R01 · FY2016 · CA · contact PI
Multifunctional matrix metalloprotease-2-sensitive anti-cancer nanopreparations$202,928
R21 · FY2015 · CA · contact PI
Center for Translational Cancer Nanomedicine$2,407,041
U54 · FY2014 · CA · contact PI
Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA$721,016
U54 · FY2014 · CA · contact PI
Multifunctional matrix metalloprotease-2-sensitive anti-cancer nanopreparations$169,106
R21 · FY2014 · CA · contact PI
Administrative Core$98,475
U54 · FY2014 · CA · contact PI
Developmental Projects and Trans-Alliance Activities$63,043
U54 · FY2014 · CA · contact PI
Center for Translational Cancer Nanomedicine$2,343,058
U54 · FY2013 · CA · contact PI
Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA$700,412
U54 · FY2013 · CA · contact PI
Layer-by-layer nanocarriers for highly efficient solubilization of insoluble drug$299,216
R01 · FY2013 · CA · contact PI
Administrative Core$95,396
U54 · FY2013 · CA · contact PI
Developmental Projects and Trans-Alliance Activities$60,771
U54 · FY2013 · CA · contact PI
Center for Translational Cancer Nanomedicine$2,529,540
U54 · FY2012 · CA · contact PI
Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA$754,495
U54 · FY2012 · CA · contact PI
Layer-by-layer nanocarriers for highly efficient solubilization of insoluble drug$325,036
R01 · FY2012 · CA · contact PI
Surface-modified pharmaceutical nanocarriers for subcellular targeting$300,503
R01 · FY2012 · CA · contact PI
Administrative Core$101,521
U54 · FY2012 · CA · contact PI
Developmental Projects and Trans-Alliance Activities$64,997
U54 · FY2012 · CA · contact PI
Center for Translational Cancer Nanomedicine$2,558,928
U54 · FY2011 · CA · contact PI
Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA$782,480
U54 · FY2011 · CA · contact PI
Layer-by-layer nanocarriers for highly efficient solubilization of insoluble drug$301,960
R01 · FY2011 · CA · contact PI
Surface-modified pharmaceutical nanocarriers for subcellular targeting$300,503
R01 · FY2011 · CA · contact PI
Administrative Core$101,536
U54 · FY2011 · CA · contact PI
Developmental Projects and Trans-Alliance Activities$65,005
U54 · FY2011 · CA · contact PI
Center for Translational Cancer Nanomedicine$2,596,014
U54 · FY2010 · CA · contact PI
Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA$853,888
U54 · FY2010 · CA · contact PI
Layer-by-layer nanocarriers for highly efficient solubilization of insoluble drug$326,209
R01 · FY2010 · CA · contact PI
Surface-modified pharmaceutical nanocarriers for subcellular targeting$309,797
R01 · FY2010 · CA · contact PI
MULTIFUNCTIONAL STIMULI-SENSITIVE PHARMACEUTICAL NANOCARRIERS$270,594
R01 · FY2010 · CA · contact PI
Administrative Core$104,661
U54 · FY2010 · CA · contact PI
Developmental Projects and Trans-Alliance Activities$67,006
U54 · FY2010 · CA · contact PI
Surface-modified pharmaceutical nanocarriers for subcellular targeting$314,097
R01 · FY2009 · CA · contact PI
Surface-modified pharmaceutical nanocarriers for subcellular targeting$309,797
R01 · FY2009 · CA · contact PI
MULTIFUNCTIONAL STIMULI-SENSITIVE PHARMACEUTICAL NANOCARRIERS$270,594
R01 · FY2009 · CA · contact PI
Surface-modified pharmaceutical nanocarriers for subcellular targeting$309,797
R01 · FY2008 · CA · contact PI
MULTIFUNCTIONAL STIMULI-SENSITIVE PHARMACEUTICAL NANOCARRIERS$270,594
R01 · FY2008 · CA · contact PI
LONG-CIRCULATING POLYMER-MODIFIED LIPOSOMES$260,510
R01 · FY2008 · HL · contact PI
Micellar Carriers for Sparingly Soluble Pharmaceuticals$336,012
R01 · FY2007 · EB · contact PI
MULTIFUNCTIONAL STIMULI-SENSITIVE PHARMACEUTICAL NANOCARRIERS$270,594
R01 · FY2007 · CA · contact PI
LONG-CIRCULATING POLYMER-MODIFIED LIPOSOMES$260,510
R01 · FY2007 · HL · contact PI
Fifth International Nanomedicine and Drug Delivery$10,000
R13 · FY2007 · EB · contact PI
Micellar Carriers for Sparingly Soluble Pharmaceuticals$346,048
R01 · FY2006 · EB · contact PI
ANTIBODY-TARGETED POLYMERIC SYSTEMS FOR TUMOR IMAGING$293,207
R01 · FY2006 · EB · contact PI
MULTIFUNCTIONAL STIMULI-SENSITIVE PHARMACEUTICAL NANOCARRIERS$278,675
R01 · FY2006 · CA · contact PI
LONG-CIRCULATING POLYMER-MODIFIED LIPOSOMES$268,291
R01 · FY2006 · HL · contact PI
Micellar Carriers for Sparingly Soluble Pharmaceuticals$354,375
R01 · FY2005 · EB
ANTIBODY-TARGETED POLYMERIC SYSTEMS FOR TUMOR IMAGING$300,263
R01 · FY2005 · EB
LONG-CIRCULATING POLYMER-MODIFIED LIPOSOMES$274,750
R01 · FY2005 · HL
Micellar Carriers for Sparingly Soluble Pharmaceuticals$354,375
R01 · FY2004 · EB
ANTIBODY-TARGETED POLYMERIC SYSTEMS FOR TUMOR IMAGING$300,789
R01 · FY2004 · EB
Long-Circulating Polymer-Modified Liposomes$237,750
R01 · FY2004 · HL
Micellar Carriers for Sparingly Soluble Pharmaceuticals$354,375
R01 · FY2003 · EB
ANTIBODY-TARGETED POLYMERIC SYSTEMS FOR TUMOR IMAGING$301,155
R01 · FY2003 · EB
Long-Circulating Polymer-Modified Liposomes$237,750
R01 · FY2003 · HL
Long-Circulating Polymer-Modified Liposomes$237,750
R01 · FY2002 · HL
MICELLAR CARRIERS FOR SPARINGLY SOLUBLE PHARMACEUTICALS$226,199
R01 · FY2002 · GM
Long-Circulating Polymer-Modified Liposomes$234,240
R01 · FY2001 · HL
MICELLAR CARRIERS FOR SPARINGLY SOLUBLE PHARMACEUTICALS$219,702
R01 · FY2001 · GM
MICELLAR CARRIERS FOR SPARINGLY SOLUBLE PHARMACEUTICALS$213,395
R01 · FY2000 · GM